Edwards Lifesciences (EW) PT Raised to $85 at Barclays

October 28, 2024 6:12 AM

Barclays analyst Matt Miksic raised the price target on Edwards Lifesciences (NYSE: EW) to $85.00 (from $80.00) while maintaining a Overweight rating.

No results found